Matthew E Pamenter Selected Research

Matthew E Pamenter Research Topics

Disease

40	Hypoxia (Hypoxemia) 10/2022 - 06/2007
3	Ischemia 01/2022 - 05/2012
3	Stroke (Strokes) 01/2012 - 06/2007
2	Reperfusion Injury 01/2022 - 05/2012
2	Neoplasms (Cancer) 10/2019 - 04/2014
2	Acidosis 01/2019 - 10/2018
2	Glioma (Gliomas) 04/2014 - 01/2014
1	Neuroinflammatory Diseases 11/2020
1	Hypercapnia 01/2020
1	Pain (Aches) 01/2020
1	Infections 10/2019
1	Inflammation (Inflammations) 10/2019
1	Hyperventilation 02/2015
1	Vascular Remodeling 03/2012
1	Pulmonary Hypertension 03/2012
1	Infarction (Infarctions) 01/2012
1	Rupture 01/2012

Drug/Important Bio-Agent (IBA)

15	Oxygen (Dioxygen)IBA 01/2022 - 11/2008
12	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2012
9	Adenosine Triphosphate (ATP)IBA 01/2022 - 11/2008
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2012
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2019
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2011 - 06/2007
3	Messenger RNA (mRNA)IBA 10/2022 - 01/2012
3	EnzymesIBA 01/2021 - 01/2018
2	Adenosine Monophosphate (AMP)IBA 01/2022 - 02/2015
2	CarbohydratesIBA 01/2022 - 01/2019
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 01/2019
2	Adenosine Triphosphatases (ATPase)IBA 11/2021 - 11/2008
2	LipidsIBA 08/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2019
2	CholesterolIBA 01/2020 - 10/2019
2	Cytochromes c (Cytochrome c)IBA 12/2019 - 01/2012
2	gamma-Aminobutyric Acid (GABA)IBA 05/2015 - 07/2011
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 04/2014 - 01/2014
2	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2012 - 03/2012
2	acetovanillone (apocynin)IBA 05/2012 - 03/2012
2	AmmoniaIBA 12/2011 - 06/2007
2	Glutamic Acid (Glutamate)FDA Link 07/2011 - 06/2007
1	IsoenzymesIBA 04/2022
1	Protein-Arginine DeiminasesIBA 04/2022
1	ProteomeIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Amino Acids FDA Link 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2022
1	lactate dehydrogenase 3IBA 01/2022
1	Ion Pumps (Ion Pump)IBA 11/2021
1	PlasticsIBA 11/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	ketohexokinaseIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	FructoseIBA 01/2021
1	Reactive Nitrogen SpeciesIBA 12/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2020
1	AntioxidantsIBA 11/2020
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2020
1	AcidsIBA 01/2020
1	Membrane LipidsIBA 01/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020
1	Substance PIBA 01/2020
1	Tricarboxylic AcidsIBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	Blood Proteins (Serum Proteins)IBA 10/2019
1	Angiotensin IIIBA 08/2019
1	Vasoconstrictor AgentsIBA 08/2019
1	Acetazolamide (Diamox)FDA LinkGeneric 10/2018
1	Ion Channels (Ion Channel)IBA 10/2018
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2018
1	mesoxalonitrileIBA 01/2018
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2018
1	Protons (Proton)IBA 01/2016
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2016
1	GABA-A Receptors (GABA(A) Receptor)IBA 05/2015
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2015
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2014
1	Cysteine (L-Cysteine)FDA Link 05/2012
1	Free Radical ScavengersIBA 05/2012
1	Coloring Agents (Dyes)IBA 05/2012
1	Free RadicalsIBA 05/2012
1	Superoxide DismutaseIBA 05/2012
1	AnionsIBA 05/2012
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 05/2012
1	Small Interfering RNA (siRNA)IBA 03/2012
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2012
1	ChromatinIBA 01/2012
1	IonsIBA 01/2012
1	Apoptosis Inducing FactorIBA 01/2012
1	Lamin Type A (Lamin A)IBA 01/2012
1	GABA-B ReceptorsIBA 07/2011

Therapy/Procedure

2	Therapeutics 05/2015 - 01/2012
1	Intraperitoneal Injections 01/2020